• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

GlucoTrack hires former Dexcom scientist as VP of sensor technology

October 14, 2022 By Sean Whooley

GlucoTrackGlucoTrack (Nasdaq:GCTK) announced today that it appointed Mark Tapsak as its vice president of sensor technology.

Tapsak, a veteran of more than 25 years in the diabetes industry, joins the company, effective immediately. His experience includes time spent as a medical device research scientist. He focused on polymer synthesis, polymer characterization, medical device design and intellectual property.

In his new role at GlucoTrack, Tapsak’s responsibilities include leading a new R&D program. The company announced earlier this week that it plans to expand its product pipeline with an R&D program. The program centers around developing a long-term continuous glucose monitor (CGM) for people with type 1 diabetes.

“GlucoTrack’s approach to advancing solutions for the management of diabetes and prediabetes is both unique and innovative,” said Tapsak. “I consider myself fortunate to be able to join this exceptional team in developing technology that has the potential to help so many.”

Tapsak brings a wealth of experience

Rutherford, New Jersey-based GlucoTrack said in a news release that Tapsak joins the company from Diabetic Health. His previous company developed coatings utilized in CGM sensors and insulin infusion sets. Tapsak served as president at Diabetic Health.

His track record includes several diabetes management companies, according to GlucoTrack. Tapsak served as senior scientist at Dexcom and senior chemist at Medtronic. His name features as an inventor on 68 patents, with more than 50 of those assigned to Dexcom.

“Mark and I worked together in the early days of development at DexCom, and I am thrilled to be working with him again”, said Paul Goode, CEO and president of GlucoTrack. “By bringing together a veteran team with proficiency in the implantable device and glucose sensing space, we are looking to bring life-changing products to market that are designed to prioritize both health and comfort, enabling freedom from the pain and inconvenience currently plaguing patients with diabetes.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Personnel Tagged With: Glucotrack, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS